Monster Beverage Corporation MNST
Composite 65/100; the shares have moved about 30% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 22/100 — a strong mark against it.
Balance-sheet strength ranks 95/100 — a strong point in its favour. Quality ranks 76/100 — a strong point in its favour. Growth ranks 70/100 — a moderate point in its favour.
Valuation ranks 22/100 — a strong mark against it.
What the company does Monster Beverage Corporation develops, markets, and sells energy drinks and non-alcoholic beverages under brands including Monster Energy, Reign, NOS, and Full Throttle. Its segments span energy drinks, strategic brands, alcohol brands, and other categories like teas and juices.
Key financials Monster reports strong profitability with ROE 26%, ROA 18%, and ROCE 29%. Margins are robust: gross 56%, operating 29%, net 23%. Revenue grew 11% and EPS 30% year-over-year. Debt is minimal (Debt/Equity 0.01), and liquidity is high (Current ratio 3.73).
Stock health Quality and strength scores are strong (76 and 95), but valuation is weak (18). Momentum is mixed: up 14% over 6 months but down 10% from its 52-week high. RSI(14) at 38 suggests modest oversold conditions.
Price vs fair value Monster trades at a discount of 11.80% versus the analyst mean target of 50.28. - PepsiCo’s North America challenges may pressure pricing power (PepsiCo's North America Challenge: Temporary or Structural?). - Analysts question whether Monster’s expansion and innovation can sustain growth (Will Monster Beverage's Expansion and Innovation Fuel Growth?). - Coca-Cola’s margin outlook highlights competitive dynamics in beverage pricing (Coca-Cola Margin Outlook: Pricing Power or Cost Relief Driving Gains?).
Looking forward Forward P/E of 41 and PEG of 6.0 suggest rich valuation despite growth. EBITDA multiples (EV/EBITDA 32) remain elevated. Free cash flow yield is low at 2%, and no dividend is paid. Growth and innovation execution will be key to closing the valuation gap.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.